UBS AM’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.3M | Buy |
343,969
+148,176
| +76% | +$4.01M | ﹤0.01% | 1390 |
|
|
2025
Q1 | $5.81M | Buy |
195,793
+21,330
| +12% | +$632K | ﹤0.01% | 1496 |
|
|
2024
Q4 | $6.91M | Buy |
174,463
+30,059
| +21% | +$1.19M | ﹤0.01% | 1442 |
|
|
2024
Q3 | $4.92M | Sell |
144,404
-17,105
| -11% | -$582K | ﹤0.01% | 1578 |
|
|
2024
Q2 | $3.5M | Buy |
161,509
+80,027
| +98% | +$1.73M | ﹤0.01% | 1693 |
|
|
2024
Q1 | $1.81M | Sell |
81,482
-390
| -0.5% | -$8.64K | ﹤0.01% | 1734 |
|
|
2023
Q4 | $2.25M | Hold |
81,872
| – | – | ﹤0.01% | 1635 |
|
|
2023
Q3 | $1.83M | Hold |
81,872
| – | – | ﹤0.01% | 1674 |
|
|
2023
Q2 | $1.83M | Hold |
81,872
| – | – | ﹤0.01% | 1703 |
|
|
2023
Q1 | $1.83M | Buy |
81,872
+2,243
| +3% | +$50K | ﹤0.01% | 1703 |
|
|
2022
Q4 | $1.89M | Buy |
79,629
+3,209
| +4% | +$76.2K | ﹤0.01% | 1550 |
|
|
2022
Q3 | $1.27M | Buy |
76,420
+761
| +1% | +$12.6K | ﹤0.01% | 1827 |
|
|
2022
Q2 | $1.51M | Sell |
75,659
-18,759
| -20% | -$373K | ﹤0.01% | 1753 |
|
|
2022
Q1 | $2.6M | Buy |
94,418
+15,687
| +20% | +$432K | ﹤0.01% | 1658 |
|
|
2021
Q4 | $3.24M | Buy |
78,731
+703
| +0.9% | +$29K | ﹤0.01% | 1623 |
|
|
2021
Q3 | $3.62M | Sell |
78,028
-2,800
| -3% | -$130K | ﹤0.01% | 1518 |
|
|
2021
Q2 | $3.23M | Buy |
80,828
+10,725
| +15% | +$429K | ﹤0.01% | 1621 |
|
|
2021
Q1 | $3.77M | Buy |
70,103
+12,253
| +21% | +$659K | ﹤0.01% | 1471 |
|
|
2020
Q4 | $2.83M | Buy |
57,850
+10,563
| +22% | +$517K | ﹤0.01% | 1546 |
|
|
2020
Q3 | $1.54M | Buy |
47,287
+5,031
| +12% | +$163K | ﹤0.01% | 1662 |
|
|
2020
Q2 | $1.09M | Sell |
42,256
-2,973
| -7% | -$77K | ﹤0.01% | 1754 |
|
|
2020
Q1 | $1.1M | Buy |
45,229
+5,136
| +13% | +$125K | ﹤0.01% | 1664 |
|
|
2019
Q4 | $1.12M | Buy |
40,093
+3,273
| +9% | +$91.4K | ﹤0.01% | 1855 |
|
|
2019
Q3 | $884K | Buy |
36,820
+9,002
| +32% | +$216K | ﹤0.01% | 2017 |
|
|
2019
Q2 | $793K | Buy |
+27,818
| New | +$793K | ﹤0.01% | 2006 |
|